Phase 1RecruitingAge-related condition
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
A Phase 1 Study To Assess The Safety And Efficacy Of OCU200 For Center-Involved Diabetic Macular Edema
- Sponsor
- Ocugen (Industry)
- Enrollment
- 24 planned
- Conditions
- Center Involved Diabetic Macular Edema; Diabetic Macular Edema
- Interventions
- OCU200
- Ages
- adults, older adults
- Registry
- NCT05802329
Full record on ClinicalTrials.gov
From the registry
A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema
Primary outcomes
- Study Drug-related adverse events (SDAE)
- Treatment-emergent adverse events (TEAEs)
- Serious adverse events (SAEs)
History
Primary completion
Last registry update
Started
Registered